FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth

Isabelle Tancioni(University of California San Diego), David D. Schlaepfer(UC San Diego Health System), Xiao Lei Chen(Xiamen University), Christine Jean(Centre National de la Recherche Scientifique), Kristy Ward(University of California San Diego), Nichol Miller(Pfizer (United States)), Sean Uryu(Pfizer (United States)), Florian J. Sulzmaier(National Foundation for Cancer Research), Christine Lawson(University of California San Diego), Nina R. Shah(Moores Cancer Center)
Molecular Cancer Therapeutics
June 5, 2014
10.1158/1535-7163.mct-13-1063
Cited by 62

Related Papers

Differential regulation of cell motility and invasion by FAK
|The Journal of Cell Biology|2003|530
Fibronectin-Stimulated Signaling from a Focal Adhesion Kinase–c-Src Complex: Involvement of the Grb2, p130 <sup> <i>cas</i> </sup> , and Nck Adaptor Proteins
|Molecular and Cellular Biology|1997|432
VEGF-Induced Vascular Permeability Is Mediated by FAK
|Developmental Cell|2012|339
Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells.
|PubMed|2001|250
FAK promotes recruitment of talin to nascent adhesions to control cell motility
|The Journal of Cell Biology|2012|218